United Therapeutics Stock Rises After Patent Victory Over Liquidia

Key Facts

1United Therapeutics shares rose Thursday following a federal court victory in patent litigation against Liquidia.

2The litigation involves Liquidia's infringement of patents held by United Therapeutics.

United Therapeutics shares rose Thursday following a federal court victory in patent litigation against Liquidia. Benzinga reported that the legal dispute involved Liquidia's infringement of patents held by United Therapeutics, with the court ruling in favor of protecting the company's intellectual property rights.

UTHR closed at $541.89 on September 30, 2026, after reaching an intraday high of $557.37. Meanwhile, Liquidia (LQDA) shares closed at $30.26 on September 30, 2026, with the stock experiencing a trading range between $29.86 and $71.93 during that session.